2020, Vol.49, No.3
323-326
Self-assembled Porphyrin-based Cage Complexes, M11L6 (M = ZnII, CdII), with Inner Coordination Sites in Their Crystal Structure
2Rigaku Corporation, 3-9-12 Matsubaracho, Akishima, Tokyo 196-8666, Japan
Herein we report self-assembled metallo-cage complexes, M11(L1)6 (M = ZnII, CdII), formed from 4-fold-symmetric ZnII-porphyrin-centered tetrakis-meso-(5′-methyl-2,2′-bipyridyl) ligands. The structures of these two D3-symmetric cages have been characterized by 1D and 2D NMR, ESI-MS, and XRD analyses. A common structural feature of these complexes is their inner molecular binding site at the axial position of each square-pyramidal ZnII-porphyrin in the crystal structure, which would provide a method to place molecular coordination sites inside or outside the cage complex with the minimum chemical modification.

Construction of porphyrin-based M11L6 cage complexes (M = ZnII, CdII) with inner coordination sites on the ZnII-porphyrin centers. Both of these isostructural structures in the solution and crystal states are characterized by NMR, ESI-MS, and single crystal XRD analyses. Notably, one CH3OH molecule coordinates to each ZnII-porphyrin center from inside the cages as a guest molecule in the crystal state.
Coordination-driven self-assembly is a powerful tool to construct cage-shaped metal complexes with a nano-sized interior space as a platform for space-specific molecular recognition and reactions. Although a large number of excellent examples of metallo-cage complexes have been reported so far,1–7 it is still a challenge to precisely arrange molecular binding sites on the inner surface. A chemically functionalized confined space with internal molecular binding sites, as can be seen in the internal binding pockets of a variety of metallo-enzymes, is a necessary requirement to acquire functional spaces with high efficiency and selectivity.
Recently, porphyrin-based self-assembled architectures, in particular, cage complexes have attracted a lot of attention because of the porphyrin-specific photochemical and redox functions.8–19 Typical examples are O-symmetric cubic cage M8L6 complexes with eight chemically equivalent metal centers as formed from 4-fold symmetric porphyrin-based ligands and metal ions.10–12 In contrast, as we previously reported,17 a self-assembled cage complex Zn11(L0·H2O)6(H2O)18(OTf)22 (L0-Zn11) with similar 4-fold symmetric porphyrin-based ligands (L0 = ZnII-porphyrin-centered tetrakis-meso-(2,2′-bipyridyl) ligand, Figure 1a) has a lower symmetry with three types of metal centers.20 This D3 symmetric M11L6 type complex L0-Zn11, formed from the C4v symmetric porphyrin ligand L0 and Zn(OTf)2, exhibits its ability to unsymmetrically encapsulate guest molecules (Tf = trifluoromethanesulfonyl).17 However, in the crystal structure, the axial ligands bind only from outside the cage to the ZnII-porphyrin centers, and there is no convincing evidence for inward binding of coordinating molecules to the ZnII-porphyrin center. Herein we report the effects of chemical modification of the porphyrin ligand from L0 to tetramethylated L1 to improve the solubility and coordination ability of the ligand. As a result, two isostructural M11(L1·CH3OH)6(H2O)18(OTf)22 (M = CdII or ZnII) cage complexes, L1-Zn11 and L1-Cd11, having six sites to which an included molecule is bonded were obtained (Figure 1b).
The ZnII-porphyrin ligand L1·H2O, a tetramethyl derivative of L0·H2O, was synthesized from 5′-methyl-2,2′-bipyridyl-5-carboxyaldehyde and pyrrole via Adler synthesis and successive complexation with Zn(OAc)2·(H2O)2 in 6.6% overall yield (Supporting Information S3), and characterized by NMR, ESI-TOF MS, and elemental analyses. The C4v symmetric structure of L1·H2O was confirmed by 1H NMR spectroscopy (Figure 2a).

Firstly, L1-Zn11 was synthesized by complexation of L1·H2O with 11/6 eq. Zn(OTf)2 in an aqueous mixed solvent, CDCl3/CD3OD/D2O = 10:10:1 (v/v/v). The reaction mixture was heated at 50 °C for 24 h. L1-Zn11 was isolated by precipitation with Et2O as a dark-green solid in 78% yield. The 1H NMR spectrum of L1-Zn11 in CDCl3/CD3OD/D2O = 10:10:1 (v/v/v) showed 32 signals in the aromatic region and 4 singlet signals in the alkyl region, suggesting the presence of a C1 symmetric L1 ligand in the self-assembled structure (Figure 2b). This spectrum was in stark contrast with a simple spectrum of ligand L1 with a C4v symmetry. Each 1H signal was fully assigned by 1H-1H COSY (Figure S9) and 1H-1H NOESY spectra (Figures S10 and S11). The interligand NOE patterns of L1-Zn11 (g1-g′2, g′1-g2, a2-a4, f2-f4, g2-f4, a3-f3, d3-g3, d3-g′3) were well matched with those of the previously reported L0-Zn11. Moreover, the presence of [Zn11L16(OTf)22−n]n+ (n = 5–7) in solution was verified by ESI-MS spectrometry (Figure S14). L1-Zn11 was further characterized by 1H DOSY (Figure S12), 19F NMR (Figure S13), and elemental analyses (Supporting Information S13).
Next, to examine the effects of metal exchange on the self-assembly, we selected CdII as a zinc group element. CdII has a larger ionic radius (ca. 0.95 Å) in an octahedral hexacoordinate geometry than that of ZnII (ca. 0.74 Å).21 In spite of the larger ionic radius of CdII and the smaller binding constants of CdII(bpy)n compared with those of ZnII(bpy)n (log β for CdII(bpy)n = 10.3 (n = 3) and 7.7 (n = 2); log β for ZnII(bpy)n = 13.2 (n = 3) and 9.5 (n = 2)),22 an isostructural L1-Cd11 was successfully obtained. Ligand L1·H2O was reacted with 11/6 eq. Cd(OTf)2·H2O in a mixed solvent, CDCl3/CD3OD/D2O = 10:10:1 (v/v/v). The reaction mixture was heated at 50 °C for 17 h. L1-Cd11 was isolated by precipitation with Et2O as a purple solid in 70% yield. In contrast, a mixture of ligand L0·H2O without methyl substituents of bipyridyl moieties and CdII did not afford any isostructural cage complexes (Figure S24). The 1H NMR spectrum of isolated L1-Cd11 in CDCl3/CD3OD/D2O = 10:10:1 (v/v/v) showed 32 signals in the aromatic region and 4 singlet signals in the alkyl region, suggesting the presence of a C1 symmetric L1·H2O ligand in the self-assembled structure (Figure 2c). Each 1H signal was fully assigned by 1H-1H COSY (Figure S16) and 1H-1H NOESY spectra (Figures S17 and S18). The interligand NOE patterns of L1-Cd11, (g1-g′2, g′1-g2, a2-a4, f2-f4, g2-f4, a3-f3, d3-g3, d3-g′3) were identical with those of L1-Zn11. However, in comparison with these two complexes, some proton signals were significantly shifted. For L1-Zn11, the protons of the pyridyl groups (e, f) attached to the ZnII-porphyrin ring at the meso positions showed downfield shift for f3 and f4 (0.28 and 0.19 ppm, respectively) and upfield shift for e2 and e4 (0.19 and 0.12 ppm, respectively). Some other signals also shifted, though to lesser extent. However, it is rather difficult to give a general explanation regarding the direction of the signal shifts. This is because there are a few factors, affecting the chemical environment of each proton, such as the different electronic perturbation from ZnII and CdII, and the structural distortion due to the larger-sized CdII. The presence of [Cd11L16(OTf)22−n]n+ (n = 5–7) in solution was verified by ESI-MS spectrometry (Figure S21). L1-Cd11 was further characterized by 1H DOSY (Figure S19), 19F NMR (Figure S20), and elemental analyses (Supporting Information S14).
The structures of L1-Zn11 and L1-Cd11 were determined by single-crystal XRD analyses (Figure 3).23 Violet crystals of L1-Zn11 and L1-Cd11 suitable for XRD analysis were obtained by vapor diffusion of Et2O into a solution of L1-Zn11 or L1-Cd11 in CDCl3/CD3OD/D2O = 10:10:1 (v/v/v), respectively. As shown in Figure 3, both [Zn11(L1·CH3OH)6(H2O)18]22+ and [Cd11(L1·CH3OH)6(H2O)18]22+ moieties contain six ligands L1 and eleven ZnII or CdII ions. For their counter anions, only six TfO− ions were solved and the remaining sixteen TfO− ions were not due to their high disorder. L1-Zn11 has three distinct ZnII centers, that is, one ZnII(bpy)3 (Zn1) and two ZnII(bpy)2(H2O)2 (Zn2, Zn3). L1-Cd11 has a similar structural framework with three distinct CdII centers, one CdII(bpy)3 (Cd1) and two CdII(bpy)2 (H2O)2 (Cd2, Cd3). Each racemic crystal with a space group R-3c (No. 167) contains two enantiomers with ΔΔΛΔΔ and ΛΛΔΛΛ configurations at the metal centers bound by bpy as shown in Figure 3. Notably, in both L1-Zn11 and L1-Cd11, one CH3OH molecule coordinates to each ZnII-porphyrin center at the axial position from inside the cavity, whereas in the previously reported L0-Zn11, one H2O molecule coordinates from outside the cavity in the crystal state (Figure 4).


The most attractive common feature of these two cage complexes, L1-Zn11 and L1-Cd11, is the presence of six inner molecular coordination sites in their crystal structure, which could enable the direct binding of included coordinating guest molecules to ZnII-porphyrin. Indeed, the inner space of each cage complex has two sets of three adjacent CH3OH molecules bound to each ZnII-porphyrin center, which are distantly positioned with a distance of 11–12 Å. By the introduction of methyl groups onto the 5′-positions of bpy moieties of methyl-free ligand L0, the space group R32 (#155) for the crystal of L0-Zn11 was changed into the space group R-3c (#167) for those of L1-Zn11 and L1-Cd11. More specifically, one bpy group of an L1-Zn11 (or L1-Cd11) complex gets close to the porphyrin ring of adjacent L1-Zn11 (or L1-Cd11) in the crystal packing, and therefore the coordination of axial CH3OH ligands from inside should be more favorable with L1-Zn11 and L1-Cd11.
The structural frameworks of L1-Zn11 and L1-Cd11 appear to be maintained in solution as confirmed by NMR and ESI-MS analyses. However, the possibility of flip-out of the axia positions on the square-pyramidal ZnII-porphyrins of L1-Zn11 and L1-Cd11 in solution remains unclear due to the fast axial ligand exchange in solution.
Figure 5 compares L1-Zn11 and L1-Cd11 (Figure 5a and 5b, respectively) for the distances between two metal centers bound by bpy: for L1-Zn11, Zn1-Zn1 = 27.455 Å, Zn1-Zn2 = 12.331 Å, and Zn2-Zn3 = 11.840 Å and 12.581 Å, and for L1-Cd11, Cd1-Cd1 = 27.745 Å, Cd1-Cd2 = 12.678 Å, and Cd2-Cd3 = 11.867 Å and 12.473 Å.
The angles between three metal centers were also calculated; for L1-Zn11, ∠Zn2-Zn3-Zn2 = 64.33°, ∠Zn4-Zn3-Zn4 = 98.31°, and for L1-Cd11, ∠Cd2-Cd3-Cd2 = 61.60°, ∠Cd3-Cd2-Cd3 = 100.07° (Figures S34 and S35). These results indicate that the whole structure of L1-Cd11 is elongated along C3-axis compared with L1-Zn11 mainly due to the larger ionic radius of CdII. Regardless of this structural change, the inner volume of L1-Cd11, 509 Å3, was almost the same as that of L1-Zn11, 511 Å3 (4.0 Å Connolly radius was used as a proof).
Guest encapsulation of L1-Zn11 and L1-Cd11 in CDCl3/CD3OD/D2O = 10:10:1 (v/v/v) was then preliminarily examined with 2,7-dinitro-9-fluorenone as a guest molecule (Figures S25–S30). However, the quantitative analysis was practically difficult due to the low solubility of 2,7-dinitro-9-fluorenone in the solvent.
In conclusion, we have newly synthesized two isostructural M11L6 complexes, L1-Zn11 and L1-Cd11, from 4-fold-symmetric ZnII-porphyrin-centered tetrakis-meso-(5′-methyl-2,2′-bipyridyl) ligands (L1) and metal ions. The self-assembled cage structures were characterized by NMR, ESI-MS, and XRD analyses. A common feature of these isostructural L1-Zn11 and L1-Cd11 complexes is the presence of their inner molecular coordination sites on the ZnII-porphyrin centers in the nano-sized cage structures. Such an approach would develop metallo-porphyrins that work as catalysts in a confined space.
This research was supported by JSPS KAKENHI Grant Nos. JP26248016 and JP16H06509 (Coordination Asymmetry) to M.S.
Supporting Information is available on https://doi.org/10.1246/cl.190943.
| 1) | Supramolecular Chemistry, 2nd ed., ed. by J. W. Steed, J. L. Atwood, Wiley-VCH, New York, 2009. |
| 2) | a) R. Chakrabarty, P. S. Mukherjee, P. J. Stang, Chem. Rev. 2011, 111, 6810. b) P. J. Stang, J. Am. Chem. Soc. 2012, 134, 11829. c) T. R. Cook, P. J. Stang, Chem. Rev. 2015, 115, 7001. Crossref, Medline, CAS |
| 3) | Z. Laughrey, B. C. Gibb, Chem. Soc. Rev. 2011, 40, 363. Crossref, Medline, CAS |
| 4) | S. Zarra, D. M. Wood, D. A. Roberts, J. R. Nitschke, Chem. Soc. Rev. 2015, 44, 419. Crossref, Medline, CAS |
| 5) | Y. Fang, J. A. Powell, E. Li, Q. Wang, Z. Perry, A. Kirchon, X. Yang, Z. Xiao, C. Zhu, L. Zhang, F. Huang, H.-C. Zhou, Chem. Soc. Rev. 2019, 48, 4707. Crossref, Medline, CAS |
| 6) | A. Galan, P. Ballester, Chem. Soc. Rev. 2016, 45, 1720. Crossref, Medline, CAS |
| 7) | L.-J. Chen, H.-B. Yang, M. Shionoya, Chem. Soc. Rev. 2017, 46, 2555. Crossref, Medline, CAS |
| 8) | J. A. Wytko, R. Ruppert, C. Jeandon, J. Weiss, Chem. Commun. 2018, 54, 1550. Crossref, Medline, CAS |
| 9) | S. Durot, J. Taesch, V. Heitz, Chem. Rev. 2014, 114, 8542. Crossref, Medline, CAS |
| 10) | a) W. Meng, B. Breiner, K. Rissanen, J. D. Thoburn, J. K. Clegg, J. R. Nitschke, Angew. Chem., Int. Ed. 2011, 50, 3479. b) J. Mosquera, B. Szyszko, S. K. Y. Ho, J. R. Nitschke, Nat. Commun. 2017, 8, 14882. c) W. Brenner, T. K. Ronson, J. R. Nitschke, J. Am. Chem. Soc. 2017, 139, 75. d) E. G. Percástegui, J. Mosquera, J. R. Nitschke, Angew. Chem., Int. Ed. 2017, 56, 9136. Crossref, Medline, CAS |
| 11) | a) M. Otte, P. F. Kuijpers, O. Troeppner, I. Ivanović-Burmazović, J. N. H. Reek, B. de Bruin, Chem.—Eur. J. 2013, 19, 10170. b) M. Otte, P. F. Kuijpers, O. Troeppner, I. Ivanović-Burmazović, J. N. H. Reek, B. de Bruin, Chem.—Eur. J. 2014, 20, 4880. Crossref, Medline, CAS |
| 12) | N. Struch, C. Bannwarth, T. K. Ronson, Y. Lorenz, B. Mienert, N. Wagner, M. Engeser, E. Bill, R. Puttreddy, K. Rissanen, J. Beck, S. Grimme, J. R. Nitschke, A. Lützen, Angew. Chem., Int. Ed. 2017, 56, 4930. Crossref, Medline, CAS |
| 13) | C. S. Wood, C. Browne, D. M. Wood, J. R. Nitschke, ACS Cent. Sci. 2015, 1, 504. Crossref, Medline, CAS |
| 14) | a) S. P. Black, D. M. Wood, F. B. Schwarz, T. K. Ronson, J. J. Holstein, A. R. Stefankiewicz, C. A. Schalley, J. K. M. Sanders, J. R. Nitschke, Chem. Sci. 2016, 7, 2614. b) D. M. Wood, W. Meng, T. K. Ronson, A. R. Stefankiewicz, J. K. M. Sanders, J. R. Nitschke, Angew. Chem., Int. Ed. 2015, 54, 3988. c) F. J. Rizzuto, D. M. Wood, T. K. Ronson, J. R. Nitschke, J. Am. Chem. Soc. 2017, 139, 11008. Crossref, Medline, CAS |
| 15) | a) F. J. Rizzuto, J. R. Nitschke, Nat. Chem. 2017, 9, 903. b) F. J. Rizzuto, W. J. Ramsay, J. R. Nitschke, J. Am. Chem. Soc. 2018, 140, 11502. Crossref, Medline, CAS |
| 16) | G. Jayamurugan, D. A. Roberts, T. K. Ronson, J. R. Nitschke, Angew. Chem., Int. Ed. 2015, 54, 7539. Crossref, Medline, CAS |
| 17) | a) T. Nakamura, H. Ube, M. Shiro, M. Shionoya, Angew. Chem., Int. Ed. 2013, 52, 720. b) T. Nakamura, H. Ube, M. Shionoya, Chem. Lett. 2013, 42, 328. Link, CAS |
| 18) | T. Nakamura, H. Ube, R. Miyake, M. Shionoya, J. Am. Chem. Soc. 2013, 135, 18790. Crossref, Medline, CAS |
| 19) | H. Ube, K. Endo, H. Sato, M. Shionoya, J. Am. Chem. Soc. 2019, 141, 10384. Crossref, Medline, CAS |
| 20) | a) D. Fujita, Y. Ueda, S. Sato, N. Mizuno, T. Kumasaka, M. Fujita, Nature 2016, 540, 563. b) D. Fujita, Y. Ueda, S. Sato, H. Yokoyama, N. Mizuno, T. Kumasama, M. Fujita, Chem 2016, 1, 91. c) A. J. Metherell, M. D. Ward, Chem. Sci. 2016, 7, 910. d) S. P. Argent, H. Adams, T. Riis-Johannessen, J. C. Jeffery, L. P. Harding, M. D. Ward, J. Am. Chem. Soc. 2006, 128, 72. Crossref, Medline, CAS |
| 21) | CRC Handbook of Chemistry and Physics 98th Ed., ed. by John R. Rumble, CRC press, Boca Raton, 2017. |
| 22) | Critical Stability Constants vol. 2, ed. by R. M. Smith, A. E. Martell, Plenum Press, New York, 1975. |
| 23) | CCDC 1967765 (L1-Cd11), and 1967766 (L1-Zn11) contain the supplementary crystallographic data for this paper. These data are provided free of charge by the Cambridge Crystallographic Data Centre: https://www.ccdc.cam.ac.uk/. |
Please login to view your saved searches.